1. Chronic pancreatitis: Medical vs Surgical treatment 소화기내과 R4 김경엽 / Prof. 동석호

2. Chronic pancreatitis Progressive inflammatory changes in the pancreas –Permanent structural damage → impairment of exocrine and endocrine function

3. Acute pancreatitis Acute inflammatory response to pancreatic injury Usually nonprogressive

4. Chronic vs Acute pancreatits Mononuclear infiltrate and fibrosis May be asymptomatic over long periods of time Serum amylase and lipase concentrations tend to be normal Neutrophilic inflammatory response Almost always painful Almost always elevated serum amylase and lipase concentrations

5. Chronic vs Acute pancreatits

6. Chronic pancreatitis

7. ETIOLOGY Alcohol abuse Genetic causes (mutations in the cystic fibrosis gene, hereditary pancreatitis) Ductal obstuction (e.g., trauma, pseudocysts, stones, tumors, possibly pancreas divisum) Tropical pancreatitis Systemic disease such as hypertriglyceridemia, SLE, possibly hyperparathyroidism) Autoimmune and idiopathic pancreatitis

8. PATHOGENESIS No complete understanding Two consistent findings –Hypersecretion of protein which is not compensated for by an increase in ductal bicarbonate secretion (impairment in ductal bicarbonate secretion: basis for the secretin pancreatic function test) –Patchy inflammatory changes within the exocrine pancreas

9. Proteinaceous ductal plugs Increased secretion of pancreatic proteins → proteinaceous plugs within the interlobular and intralobular ducts → nidus for calcification → stone formation within the duct system → formation of ductal epithelial lesions which scar and obstruct the ducts → inflammatory changes and cell loss Formation of plugs within some but not all of the ducts explains the patchy nature of this disease

10. Ischemia (1) Experimental canine model –Ligation and separation of branches flowing into the left pancreatic lobe from the splenic artery → chronic ischemia of pancreas → chronic pancreatitis –3 and 6 months after → pancreas was hard, with severe inflammatory change

11. Ischemia (2) Ischemia is important in exacerbating or perpetuating rather than initiating disease Canine and feline models of partial pancreatic duct ligation (may be analogous to plug and stone formation in human chronic pancreatitis) → ductal hypertension –Vascular perfusion decreased further following secretory stimuli –This model explains why ductal decompression improves chronic pancreatitis

12. Antioxidants Nutritionally depleted in patients with chronic pancreatitis –Antioxidants such as selenium, vitamins C and E, and methionine Imbalance between a decrease in antioxidants and an increased demand for them in “stressed cells” → elevations in free radical formation → lipid peroxidation and cellular impairment Controlled trials are needed

13. CLINICAL FEATURES Two primary clinical manifestations of chronic pancreatitis –Abdominal pain –Pancreatic insufficiency

14. Clinical course of chronic pancreatitis

15. J Gastroenterol 2003;38:315-326

17. Abdominal pain Cardinal feature of chronic pancreatitis Typically epigastric, often radiates to the back Pain pattern in chronic pancreatitis varies among patients

18. Pancreatic insufficiency Fat malabsorption –Loose, greasy, foul smelling stools –Malabsorption of the fat soluble vitamins (A, D, E, K) and vitamin B12 (clinically symptomatic vitamin deficiency is rare) Pancreatic diabetes

19. Complications Pseudocyst formation Bile duct or duodenal obstruction Pancreatic ascites or pleural effusion Splenic vein thrombosis Pseudoaneurysms Pancreatic cancer

20. TREATMENTS Pain management Pancreatic exocrine insufficiency

21. PAIN MANAGEMENT

22. AGA guideline for treatment of pain in chronic pancreatitis

23. Establish a secure diagnosis Rule out other potential etiologies, including peptic ulcer disease, biliary obstruction, pseudocysts, pancreatic carcinoma,and pancreatic duct stricture or stones

24. Cessation of alcohol intake Abstinence does not always lead to symptomatic improvement Patients with alcohol-induced chronic pancreatitis who continue to drink have increased mortality

25. Small meals Small meals that are low in fat may help to varying degrees

26. Pancreatic enzyme supplements Relieve pain in some patinets Not very effective Rationale –Suppression of feedback loops in the duodenum that regulate the release of cholecystokinin (CCK), the hormone that stimulates digestive enzyme secretion from the exocrine pancreas

27. Analgesics Analgesia can be considered if pancreatic enzyme therapy fails to control pain Chronic opioid analgesia may be required in patients with persistent significant pain

28. Celiac nerve block Percutaneous or endoscopic celiac nerve blocks with either alcohol or steroids –Limited success –Unproven therapy –Even among responders, symptoms frequently recur within two to six months

29. Extracorporeal shock wave lithotripsy 22 to 60% of patients with chronic pancreatitis have pancreatic duct stones Stones → obstruction of the outflow of pancreatic secretions → increased intraductal pressure ESWL creates millimetric fragmentation of pancreatic stones, which has improved the results of endoscopic therapy

30. Endoscopic therapy (1) Decompressing an obstructed pancreatic duct can be associated with pain relief in some patients Rationale –The hypothesis that ductal hypertenstion due to sphincter of Oddi dysfunction or strictures of the main pancreatic duct lead to pain Objection –Spontaneous pain relief in some chronic pancreatitis

31. Endoscopic therapy (2) Long-term follow-up (average 5 years), 1018 patients, 8 centers –Obstruction of the pancreatic duct Strictures (47%), stones (18%), strictures plus stones (32%) –60% had completed endoscopic therapy –16% were still undergoing some form of endoscopic follow-up –24% had undergone surgery –Pain relief: 65% of patients on intention-to-treat analysis –No improvement of pancreatic function

32. Endoscopic therapy (3) Best Pract Res Clin Gastroenterol 2004

33. Endoscopic therapy (4) Pancreatic duct stenting

34. Endoscopic therapy (5) Issues –Retrospective studies –Good early response –No effectiveness in long-term periods –Relatively safe, but risk of complications –Need experienced and skillful endoscopic techniques –Expensive instruments (e.g., ESWL)

35. Surgery

36. PAIN MANAGEMENT Medical vs Surgical treatment

37. Risk factors of treatment failure of biliary stent in chronic pancreatitis Biliary stent insertion (61 patients) (prospective) –Replacement of stent every 3 months –Removal of stent after 1 year –40 months long-term treatment success rate 26% Calcification of panreatic head portion treatment success rate (+) 7.7% (-) 59.1% Calcification of pancreatic head portion –Predictive factor for treatment success rate Am J Gastroenterol 2003

38. Long-term effect of biliary stent in chronic pancreatitis Biliary stent insertion (58 patients) (retrospective) –Replacement of stent every 3 months –Removal of stent after 1 year –45 months long-term treatment success rate 38% –Combined with acute pancreatitis: treatment success rate 92% (biliary compression by inflammation) –Stenosis due to fibrosis Low success rate (24%) Eur J Gastroenterol Hepatol 2005

39. Surgical drainage operations Gastroenterology 1998;115:765-776

40. A prospective, randomized trial: endoscopic and surgical therapy 140 patients (randomized 72 patients), 5 years long-term follow-up OperationEndoscopic therapy Loss of pain37(34)%14(15)% Relief of pain49(52)%51(46)% Long-term effect of treatment –Surgery > endoscopic therapy 1 st line therapy: non-invasive endoscopic therapy Endoscopy 2003

41. 요 약요 약 만성췌장염의 치료는 현재까지 전향적 대조 연구가 부족하므 로 치료방침이 담당의사의 경험에 따르게 된다. 췌관석, 췌관협착, 담관협착, 가성낭 등의 치료방법으로 내시경 적 치료와 수술적 치료 중 어느 것을 선택할 것인지는 환자의 상태뿐 아니라 의사의 경험도 많이 작용하게 된다. 내과적 치료에 반응하지 않는 통증의 경우 수술을 계획하기 전 에 celiac plexus block 이나 epidural block 을 먼저 고려해야 한 다.